FolioLanternBeta
ADPTAdaptive Biotechnologies Corp

Chad Robins

CEO and Chairman, Director at Adaptive Biotechnologies Corp, as of Aug 19, 2026Sold $39.8M of stock in the past 12 months: 47% under a disclosed plan, 16% to cover taxes and 37% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
2.18M
shares held after the latest filing, Adaptive Biotechnologies Corp
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
2.22M
shares sold, past 12 months
15
days with sales
$8.1M
largest single day, Aug 17, 2026
1
company filed for

Share of stake sold at Adaptive Biotechnologies Corp is not shown: the same shares may be reported by another insider. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $2.0M under a disclosed planNovDec 2025: $2.4M under a disclosed planDecJan 2026: $1.9M under a disclosed planJanFeb 2026: $5.2M under a disclosed planFebMar 2026: $5.4M under a disclosed planMar 2026: $6.2M to cover taxesMarApr 2026: $1.8M under a disclosed planAprMayJunJulAug 2026: $14.9M no plan disclosed$14.9MAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Adaptive Biotechnologies Corp (ADPT)CEO and Chairman, DirectorJun 26, 2019Aug 19, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.